[An experimental study of acute toxicity and pharmacology of fermented Platycodonis Radix]

Yan-Li Meng1, Nan-Nan Liu1, Yan Jiang1

  • 1Heilongjiang Academy of Chinese Medicine Sciences Harbin 150036, China.

Insights

Fermented Platycodonis Radix demonstrates no acute toxicity in mice. It effectively suppresses cough by reducing the expression of TRPA1, CGRP, and SP in lung tissue, indicating its therapeutic potential.

Area of Science:

  • Pharmacology
  • Traditional Chinese Medicine
  • Respiratory Medicine

Context:

  • Mycoplasma pneumoniae infection is a common cause of respiratory illness and cough.
  • Fermented Platycodonis Radix is a traditional herbal medicine with potential therapeutic properties.
  • Understanding the mechanisms of cough suppression is crucial for developing effective treatments.

Purpose:

  • To evaluate the acute toxicity of fermented Platycodonis Radix in mice.
  • To investigate the efficacy of fermented Platycodonis Radix in suppressing cough in a mouse model of Mycoplasma pneumoniae infection.
  • To elucidate the molecular mechanisms underlying the anti-tussive effects of fermented Platycodonis Radix.

Summary:

  • Acute toxicity studies showed no adverse effects or mortality in mice treated with fermented Platycodonis Radix.
  • Pharmacological experiments revealed that fermented Platycodonis Radix significantly reduced cough latency and count in mice infected with Mycoplasma pneumoniae.
  • Histopathological examination and molecular analysis (qRT-PCR, immunohistochemistry) indicated that fermented Platycodonis Radix suppressed the expression of transient receptor potential A1 (TRPA1), calcitonin gene-related peptide (CGRP), and substance P (SP) in lung tissues.

Impact:

  • Fermented Platycodonis Radix exhibits a favorable safety profile.
  • The study identifies fermented Platycodonis Radix as a potential natural remedy for cough associated with respiratory infections.
  • The findings provide mechanistic insights into the anti-tussive action of fermented Platycodonis Radix by targeting TRPA1, CGRP, and SP pathways.

Related Concept Videos